What is Windfall Bio?
Headquartered in Menlo Park, California, Windfall Bio operates at the intersection of climate technology and regenerative agriculture. The company has developed a sophisticated biological process that captures dilute methane emissions and transforms them into high-value organic soil nutrients. By bridging the gap between industrial waste management and sustainable farming, Windfall Bio addresses two critical global challenges: the reduction of potent greenhouse gases and the enhancement of soil health. The company's interdisciplinary team of biologists, agricultural experts, and business leaders is focused on deploying these natural innovations to create a circular agricultural economy that supports both global food security and environmental restoration.
How much funding has Windfall Bio raised?
Windfall Bio has raised a total of $37M across 2 funding rounds:
Angel/Seed
$9M
Series A
$28M
Angel/Seed (2023): $9M with participation from Cavallo Ventures, Breakthrough Energy Ventures, B37 Ventures, Bessemer Venture Partners, and Mayfield
Series A (2024): $28M led by Prelude Ventures
Key Investors in Windfall Bio
Prelude Ventures
An investment firm dedicated to supporting early-stage startups with significant potential to mitigate climate change across sectors like food, agriculture, and carbon management.
Breakthrough Energy Ventures
A mission-driven venture capital firm backed by global leaders, focused on funding cutting-edge companies that can significantly reduce emissions to achieve net-zero by 2050.
Cavallo Ventures
The venture capital arm of Wilbur Ellis, specializing in introducing innovative technologies to the agricultural sector to maximize customer returns and operational efficiency.
What's next for Windfall Bio?
Following this major enterprise-level funding, Windfall Bio is expected to prioritize the commercial scaling of its methane-capture technology. The strategic infusion of capital will likely facilitate the expansion of pilot programs into full-scale industrial deployments, allowing the company to refine its supply chain and deepen its market penetration. As the firm moves beyond its initial development phase, the focus will shift toward optimizing unit economics and establishing long-term partnerships with large-scale agricultural producers. By leveraging the expertise of its high-profile investor base, Windfall Bio is poised to become a critical player in the global transition toward net-zero emissions, effectively turning environmental liabilities into productive agricultural assets.
See full Windfall Bio company page
